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A Basis for SUMO Protease Specificity
Provided by Analysis of Human Senp2
and a Senp2-SUMO Complex
Although structurally similar, SUMO-1 shares only 14%
sequence identity with ubiquitin (Saitoh et al., 1997; Yeh
et al., 2000) (Figure 1). Recent studies showed the total
fraction of SUMO-2/3 in the cell to be greater than that
observed for SUMO-1 and that the existing nonconju-
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gated pool of SUMO-2/3 can be converted to conjugated
high molecular mass proteins upon stress stimuli (SaitohSummary
and Hinchey, 2000). Somewhat analogous to ubiquitin,
SUMO-2 and SUMO-3 have been observed to form poly-Modification of cellular proteins by the ubiquitin-like
meric chains in vitro; and while SUMO-2 chains haveprotein SUMO is essential for nuclear metabolism and
been detected in vivo, their significance remains unclearcell cycle progression in yeast. X-ray structures of
(Tatham et al., 2001).the human Senp2 catalytic protease domain and of a
SUMO is covalently attached to protein targets throughcovalent thiohemiacetal transition-state complex ob-
an isopeptide bond that occurs through a lysine -aminotained between the Senp2 catalytic domain and SUMO-1
group on the protein target and the SUMO C terminusrevealed details of the respective protease and substrate
in a process analogous to that of ubiquitin activationsurfaces utilized in interactions between these two pro-
and conjugation (Hershko and Ciechanover, 1998). Priorteins. Comparative biochemical and structural analy-
to activation, SUMO is proteolytically processed fromsis between Senp2 and the yeast SUMO protease Ulp1
its precursor form to produce a conserved C-terminalrevealed differential abilities to process SUMO-1,
Gly-Gly motif (Figure 1). ATP-dependent activation ofSUMO-2, and SUMO-3 in maturation and deconjuga-
SUMO is catalyzed in two steps by a SUMO-specific E1tion reactions. Further biochemical characterization
enzyme through adenylation of the C-terminal glycine,of the three SUMO isoforms into which an additional
and transfer of the adenylate to a conserved E1 cysteineGly-Gly di-peptide was inserted, or whereby the re-
in a reaction that releases AMP and results in an E1-spective SUMO tails from the three isoforms were
SUMO thioester linkage. The E1-SUMO thioester is thenswapped, suggests a strict dependence for SUMO iso-
competent for isoenergetic thioester transfer to a cys-peptidase activity on residues C-terminal to the con-
teine in Ubc9, the SUMO-specific E2 conjugating pro-served Gly-Gly motif and preferred cleavage site for
SUMO proteases. tein. Although several SUMO-specific E3 cofactors have
been identified in recent years, Ubc9 directly interacts
with nearly all SUMO targets in vitro through a consen-Introduction
sus SUMO motif, thus facilitating direct transfer of
SUMO to a lysine -amino group within the protein targetUbiquitin and ubiquitin-like proteins contribute to regu-
(Bernier-Villamor et al., 2002; Melchior et al., 2003).lation of cellular pathways involved in apoptosis, differ-
SUMO conjugation may be additionally regulated byentiation, development, responses to stress, and the
various E3 cofactors (Melchior et al., 2003), althoughcell cycle. Ubiquitin and ubiquitin-like family members
several observations suggest that levels of SUMO conju-are 8–11 kDa proteins that are observed conjugated to
gated material can also be regulated by the action oftarget proteins via an isopeptide bond between ubiquitin
proteases that catalyze SUMO deconjugation (Li andand a lysine of the protein target (Hershko and Ciechan-
Hochstrasser, 1999, 2000). Functional overlap has beenover, 1998; Hochstrasser, 1998; Laney and Hochstras-
uncovered for the two SUMO deconjugating proteasesser, 1999; Saitoh et al., 1997). The SUMO protein family
identified in S. cerevisiae, but only Ubl-specific proteasebelongs to a group of ubiquitin-like modifiers that is
1 or Ulp1 is essential in yeast. Genetic and biochemicalobserved in organisms ranging from yeast to human.
The budding yeast Saccharomyces cerevisiae contains analysis suggests that Ulp1 catalyzes two critical func-
one SUMO ortholog named Smt3 (Meluh and Koshland, tions in the SUMO pathway via an encoded cysteinyl
1995), and SUMO conjugation in yeast appears critical proteinase activity, it processes the Smt3 C-terminal
for septin ring formation, chromosomal segregation, and sequence (-GG-ATY) to its mature form (-GG), and it
progression of the cell cycle through G2-M (Johnson and deconjugates Smt3 from the lysine -amino group of
Blobel, 1999; Takahashi et al., 1999; Tanaka et al., 1999; the protein target (Li and Hochstrasser, 1999). Ulp1 has
Li and Hochstrasser, 1999). been localized to the nuclear pore complex, and this
Mammals contain at least three SUMO family mem- localization appears critical for its function (Panse et
bers, SUMO-1, SUMO-2, and SUMO-3. SUMO-2 and al., 2003). In contrast, Ulp2 is primarily observed in the
SUMO-3 share only 43% and 42% identity to SUMO-1, nucleus, and while Ulp2 is not essential, yeast strains
respectively, but are highly related and share greater containing the Ulp2 null mutation have profound cellular
than 96% sequence identity to each other. S. cerevisiae defects that include a temperature-sensitive growth, ab-
Smt3 shares 43% amino acid identity with mammalian normal cell morphology, decreased plasmid and chro-
SUMO-1, 39% with SUMO-2, and 40% with SUMO-3. mosome stability, and severe sporulation defects (Li
and Hochstrasser, 2000). Most importantly, comparative
analysis of Ulp1 and Ulp2 conditional alleles reveal com-*Correspondence: lima@limalab.org
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plex patterns of substrate specificity (Li and Hochstras- Results and Discussion
ser, 2000).
Structure of Human Senp2 Protease CatalyticBiochemical and bioinformatic approaches have iden-
Domain Alone and in Complex with SUMO-1tified at least seven Ulp1 protease orthologs in human
H. sapiens Senp2 is a 589 amino acid protein that con-(termed Senp1–3 and Senp5–8) (Yeh et al., 2000; Mel-
tains a C-terminal Ulp-like catalytic domain. Based onchior et al., 2003) (Figure 1). As stated previously, sub-
our previous structural characterization of Ulp1, a Senp2strate specificity has been observed through analysis
fragment that included amino acid residues 364–589of Ulp1/Ulp2 function in yeast, and although preliminary,
was constructed and expressed in E. coli (see Experi-the greater diversity of human Senp family members
mental Procedures). For clarity, we will refer to this frag-suggests that SUMO proteases could play significant
ment as Senp2 throughout the remainder of the paper.roles in regulating levels of SUMO conjugation through
Our previous studies on the Ulp1 protease were unablelocalization or specific interaction with SUMO-conju-
to address whether the catalytic domain exists in angated proteins. For instance, Senp3 (also known as
active or inactive form prior to interaction with SUMOSmt3IP1) appears proficient in deconjugating SUMO2/3
since the structure of Ulp1 was only solved in the contextconjugates, but appears unable to process SUMO pre-
of the Ulp1-Smt3 complex (Mossessova and Lima,cursors to their mature form under similar conditions
2000). To gain insights into the activation and specificity(Nishida et al., 2000). Senp6 (also known as SUSP1)
determinants of Senp2 in the absence of SUMO-1, theis localized to the cytoplasm and appears to exhibit
Senp2 catalytic domain was purified to homogeneity,specificity toward SUMO-1 (Kim et al., 2000).
crystallized, and X-ray diffraction data were collected.The enzymatic properties of Senp2 have also been
The Senp2 structure contains two independent mole-characterized (Nishida et al., 2001; Zhang et al., 2002),
cules in the crystallographic asymmetric unit and wassuggesting that this nuclear enzyme is able to deconju-
solved by molecular replacement using the Ulp1 cata-gate RanGAP-SUMO-1, -SUMO-2- and -SUMO-3 and is
lytic domain as a search model. The model was refinedable to hydrolyze all three SUMO precursors in vitro.
to 2.2 A˚ with an R factor and Rfree of 20.2% and 24.3%,Senp1 is most similar to Senp2, sharing 57% sequence
respectively (Table 1; see Experimental Procedures).identity in the catalytic domain. Senp1 is also nuclear
The two independent Senp2 catalytic domains locatedand appears capable of cleaving SUMO-1 and SUMO-3
within the asymmetric unit are similar and can be super-protein conjugates in vivo (Gong et al., 2000). Interest-
imposed within 0.21 A˚ root-mean-square deviationingly, a Senp ortholog was originally identified as a Ulp/
(rmsd) over 204 C atoms.Senp family member (termed Senp8), but was later
The complex between Senp2 and SUMO-1 was pro-shown to encode deconjugating activity against the
duced by trapping a chemically stable transition statesmall ubiquitin-like modifier Nedd8 (Gan-Erdene et al.,
analog between SUMO-1 and Senp2 using sodium boro-2003; Wu et al., 2003; Mendoza et al., 2003), indicating
hydride (NaBH4) to selectively cleave and reduce thethat Ulp/Senp family members can adapt to interact with
deacylation intermediate of the proteolytic reactionproteins other than SUMO.
(Pickart and Rose, 1986; Mossessova and Lima, 2000).In several cases, the cellular localization of Senp/Ulp
This process results in a covalent thiohemiacetal bondfamily members has been postulated to play an impor-
between the Senp2 active site cysteine (Cys548) andtant role in Senp/Ulp function. Senp2 associates with
the C-terminal SUMO-1 glycine (Gly97; see Experimentalthe nuclear face of the nuclear pore, and restricts Senp2
Procedures). Diffraction quality crystals were obtainedactivity to a subset of the conjugated proteins within
between a 17 amino acid N-terminal deletion of SUMO-1
the nucleus (Hang and Dasso, 2002; Zhang et al., 2002).
(SUMO-1[18-97]p and Senp2[364-589]p). The structure
Ulp1 appears to be a functional homolog of Senp2 as
of the complex was solved by molecular replacement
it is also localized at the nuclear pore complex through
using the Senp2 catalytic domain, revealing one Senp2-
interactions between the Ulp1 N-terminal domain and SUMO-1 complex per asymmetric unit. The model for
karyopherins that are associated with nucleoporins SUMO-1 was manually built using the crystal structure
(Panse et al., 2003). Senp1 has also been shown to be of Smt3 as a starting point. The final model was refined
localized to the nucleus (Bailey and O’Hare, 2004), and to 2.8 A˚ with a R factor and Rfree of 21.4% and 27.5%,
deletions of the N-terminal domain mislocalize Senp1 respectively (Table 1). Electron density for Senp2 was
and alter the pattern of SUMO conjugates in vivo. apparent for a continuous polypeptide chain from
To reveal specific interactions between human SUMO-1 Leu366 to Leu589 while electron density for SUMO-1
and a Senp family member and to reveal the underlying was observed for a continuous polypeptide chain from
principles in recognition of sumoylated proteins and the Glu20 through to the C-terminal Gly97. As expected, the
properties of the Senp catalytic domain, we have deter- distance observed between the SUMO-1 Gly97 carbonyl
mined the 2.2 A˚ resolution X-ray structure of a proteolyti- carbon atom and the Senp2 Cys548 sulfur atom sug-
cally active human Senp2 C-terminal fragment alone gested the presence of a covalent bond between these
and the 2.8 A˚ resolution X-ray structure of a complex two atomic positions.
between Senp2 and human SUMO-1. Further biochemi- The Senp2 structure confirms its relationship to the
cal, structural, and sequence analysis reveal aspects Ulp/Senp protease clan, and analogous secondary
of Senp/Ulp protease activities that are responsible for structure elements observed in the Ulp1 catalytic do-
deconjugation and maturation of SUMO-1, SUMO-2 and main are also observed in the Senp2 structure (Figure
2A) (Mossessova and Lima, 2000). For clarity, the Senp2SUMO-3 isoforms.
Structure of Senp2 and a Senp2-SUMO Complex
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Figure 1. Structure-Based Sequence Alignment of Senp/Ulp1 and SUMO Family Members
(A) Sequence alignment of the catalytic domain of the human Senp family based on structural alignment of human Senp2 and S. cerevisiae
Ulp1. Gaps are denoted by single dot. Senp2 amino acid numbering shown above the alignment with respect to full-length Senp2 and Ulp1
amino acid numbering shown below alignment with respect to full-length Ulp1. The Senp2 (blue) and Ulp1 (yellow) secondary structural
elements are shown above and below the alignment, respectively, with  strands numbered, helices lettered, and coil depicted as a line. Side
chain identity is denoted in the alignment with a black background; side chain homology (75% conservation in all sequences) is denoted with
a gray background. Conserved catalytic residues in the entire family are shown in red. Red and black asterisks shown above and below the
alignment indicate Senp2 or Ulp1 residues in direct contact with either SUMO-1 or Smt3, respectively. Ulp1 motifs 1–6 as described in
Mossessova and Lima (2000) are labeled in black below the Ulp1 sequence.
(B) Sequence and structure-based alignment of human SUMO-1 with respect to S. cerevisiae Smt3. Sequences of human SUMO-2, SUMO-3,
human ubiquitin, and Nedd8 are aligned to human SUMO-1. The SUMO-1 (brown) and Smt3 (yellow) secondary structures are shown above
and below the sequence alignment, respectively, with  strands numbered, helices lettered, and coil depicted as a line. Amino acid numbering
for human SUMO-1 is shown above the alignment, and amino acid numbering for S. cerevisiae Smt3 is shown below the sequence alignment.
Red and black asterisks indicate either SUMO-1 or Smt3 residues in direct contact with either Senp2 or Ulp1, respectively.
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Table 1. Crystallographic Data
Senp2 Senp2-SUMO-1
PDB ID 1THO 1TGZ
Source NSLS X4A APS 31-ID
Wavelength (A˚) 0.9790 0.9790
Resolution limits (A˚) 20–2.0 20–2.6
Space group C2 P6522
Unit cell (A˚) a  123.24, b  59.23, a  b  111.63, c  143.11
c 94.01; 111.29
Number of observations 258,351 775,500
Number of reflections 36,110 15,675
Completeness (%) 99.1 (99.4) 94.3 (85.4)
Mean I/I 20.1 (2.6) 10.8 (0.9)
R merge on Ia 7.3 (48.0) 12.9 (84.1)
Cut-off criteria I/I 2 1
Refinement Statistics
Resolution limits (A˚) 20–2.2 20–2.8
Number of reflections 32,301 13,430
Completeness (%) 99.1 97.0
Cutoff criteria I/I 0 0
Molecules asymmetric unit 2 1
Residues/atoms 225/1,872 (Senp2) 223/1,861 (Senp2) – 77/610
(SUMO-1)
Number of water atoms 209 81
Number of sulfate atoms 5
Rcrystb 0.20 (0.29) 0.21 (0.41)
Rfree (5% of data) 0.24 (0.32) 0.27 (0.39)
Bonds (A˚) 0.006 0.007
Angles () 1.18 1.32
B factor (mc/sc in A˚2) 1.4/2.1 1.2/2.0
Data in parentheses indicate the statistics for date in the highest resolution bin. mc, main chain B factors; sc, side chain B factors.
a Rmerge  hkl i|I(hkl)i  	I(hkl)
|/hkli 	I(hkl)i
.
b Rcryst  hkl |Fo(hkl)  Fc(hkl)|/hkl |Fo(hkl)|, where Fo and Fc are observed and calculated structure factors, respectively.
structure can be subdivided into two subdomains, an SUMO-1 was utilized in the Senp2-SUMO-1 complex,
two additional amino acids (18–19) were disordered andN-terminal segment rich in  helices that contains the
protease nucleophile (Cys548; located at the N-terminal could not be observed. A flexible N-terminal region was
also observed for SUMO-1 in the NMR structure andend of the central helix F), and a C-terminal subdomain
formed by a central antiparallel five-stranded  sheet for Smt3 within the context of the Ulp1-Smt3 complex
(Bayer et al., 1998; Mossessova and Lima, 2000). Al-surrounded by two  helices. The C-terminal subdomain
contains the His478 and Asp495 from the protease cata- though some differences were observed when compar-
ing the Senp2 structure with the Senp2-SUMO-1 com-lytic triad located in 5 and 6, respectively.
As was expected, a search of the PDB using DALI plex, neither Senp2 or SUMO-1 appear to alter their
overall topology in response to interaction, indicating(Holm and Sander, 1993) showed that Senp2 shares the
highest degree of structural similarity with Ulp1 (1.4 A˚ that large conformational changes are not required for
complex formation (Figure 2).rmsd over 210 superimposed C atoms with 32% se-
quence identity). The second top score in the DALI PDB A PDB search using DALI (Holm and Sander, 1993)
and our structure of SUMO-1 showed the highest degreesearch is to the adenoviral protease-1 fragment (AVP1)
with a 3.3 A˚ rmsd over 136 matching C atoms with of structural similarity to the crystal structure of yeast
Smt3 with an rmsd of 1.4 A˚ over 77 matching C atoms16% sequence identity (Ding et al., 1996). The AVP-1
structure represented the prototype of a unique family with 48% sequence identity. The second and third high-
est scores were assigned to ubiquitin (PDB 1UBI, 1.9 A˚of cysteine proteases that now includes Ulp1 and other
putative desumoylating and deneddylating enzymes. Al- over 61 matching C atoms with 11% sequence identity)
and Hub1 (PDB 1M94, 2.2 A˚ over 60 matching C atomsthough AVP1 has been reported to encode deubiquiti-
nating activity (Balakirev et al., 2002), its primary physio- with 10% sequence identity). The fourth and fifth highest
scores were assigned to the elonbin b (PDB 1VCB) and alogical role is believed to involve the processing of viral
precursor proteins during virion maturation (Mangel et region of the moesin ferm domain (PDB 1EF1). Although
identical with respect to sequence, the NMR structureal., 1993).
The structure determination of the Senp2-SUMO-1 of SUMO-1 was sixth on the scored list with only 63
amino acids aligning to an rmsd of 2.7 A˚ over 61 match-complex reveals the first crystal structure for SUMO-1
(as observed in complex with Senp2) and reveals ing C atoms. While different from the NMR structure,
we do not believe SUMO-1 undergoes large conforma-SUMO-1 secondary structure elements that are con-
served throughout the ubiquitin protein family (Figure tional changes upon interaction with Senp2. SUMO-1
C-terminal residues remain highly flexible in the SUMO-12B). Although a 17 amino acid N-terminal deletion for
Structure of Senp2 and a Senp2-SUMO Complex
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activity and activation of the cysteine as a nucleophile.
Senp2 undergoes local structural rearrangements in re-
sponse to binding SUMO-1 (Figure 3). His478 undergoes
a 180 rotation in the Senp2-SUMO-1 complex such that
the imidazole ring now points directly toward Asp495
and away from Cys548. In addition, Trp410 and Trp479
and the imidazole group of His474, residues that interact
directly with SUMO-1, all rotate about their C atoms
to adapt to interactions with the SUMO-1 C-terminal
Gly-Gly motif (Figure 3).
The Senp2 structure can be aligned to Senp2 in com-
plex with SUMO-1 with a 0.41 A˚ rmsd over 210 C atoms.
While similar in many respects, some notable differ-
ences are observed when the Senp2 structures are
aligned based on either the N-terminal (Asp364 to
Tyr432 and Pro540 to Leu589) or C-terminal subdomains
(Tyr432 to Pro540) (Figure 3). If the N-terminal subdo-
main is aligned, a significant shift can be observed
throughout the C-terminal subdomain that results in
1.5 A˚ differences between regions that includeE helix
and 7. Deviations appear to originate within the Senp2
C-terminal domain near Pro444 and Pro540, and as de-
picted in Figure 3, the shift of the C-terminal domain
facilitates SUMO-1 interaction insomuch as the sub-
strate binding cleft opens by 1 A˚ to enable contacts
between the C-terminal residues of SUMO-1 and the
Senp2 active site. These interactions include contacts
between the conserved SUMO-1 3-4 loop (Glu67-
Gly68) and side chains of Arg456 and Trp457 of Senp2.
Despite the observed local conformational changes,
Senp2 does not appear to be activated by interaction
with SUMO insomuch as Senp2 appears catalytically
competent in its apo form. This is dissimilar from that
observed for HAUSP, a recently characterized member
of the UBP family of ubiquitin-specific proteases (Hu et
al., 2002). In this structure, the HAUSP catalytic cysteine
Figure 2. Structure of Senp2 and Senp2-SUMO-1 is misaligned and located 9.7 A˚ from the catalytic histi-
(A) Ribbon representation of the secondary structure of the human dine in an inactive state prior to interaction with sub-
Senp2 catalytic domain.  strands are numbered and  helices strate, in this case, ubiquitin-conjugated P53. Another
are lettered. Catalytic residues are numbered and shown in bond
notable example of protease regulation via active siterepresentation.
misalignment was observed in the structure of calpain,(B) Ribbon representation of the secondary structure of the human
Senp2 catalytic domain (dark blue) in complex with human SUMO-1 a ubiquitous cysteine protease that is active only in
(brown).  strands are numbered and  helices are lettered. Senp2 the presence of Ca2. In this case, Ca2 triggers the
catalytic residues are numbered and shown in bond representation. alignment of the catalytic triad of the active site (Moldo-
Graphics prepared using Pymol unless otherwise noted (DeLano, veanu et al., 2002).
2002).
Deubiquitinating (DUB) enzymes share no sequence
or structural similarity to the Ulp1/Senp protease family,
although Ulp and DUB enzymes both belong to a largerNMR structure, but undergo similar rearrangement to
group of cysteine proteases that recognize and cleavethat observed in the Ulp1-Smt3 complex by adopting
C-terminal to the conserved C-terminal Gly-Gly motifan extended -like conformation that terminates with
found in nearly all known ubiquitin or ubiquitin-like pro-a covalent bond between the Gly97 and the catalytic
teins (Hochstrasser, 1996; Wilkinson, 1997). The ubiqui-Cys548 in the Senp2-SUMO-1 complex (Figures 2B
tin C-terminal hydrolase family (UCH) represents a DUBand 3).
subfamily that is unable to hydrolyze ubiquitin from large
protein conjugates, but is able to catalyze proteolysis
The Senp2 Active Site Alone and in Complex of small molecular weight ubiquitin adducts. The crystal
with SUMO-1 structures of a human and a yeast UCH enzyme in com-
The Senp2 active site resembles other cysteine protease plex with ubiquitin aldehyde revealed the mechanism
active sites and is formed by a catalytic triad of amino for this selectivity in that recognition of the C-terminal
acid residues that includes Cys548, His478, and Asp495. Ub/Ubl Gly-Gly motif was accomplished by a21 amino
Cys548 and His478 are located 3.9 A˚ from each other acid crossover loop that folds down on the Ub-aldehyde
on opposite sides of the active site cleft, consistent with Gly-Gly motif to provide a steric block to UCH interaction
with large ubiquitin adducts (Johnston et al., 1997, 1999).traditional roles attributed to these residues for catalytic
Structure
1524
Figure 3. Structural Superposition of Senp2 and the Senp2-SUMO-1 Complex
Stereo representation of Senp2 alone (light blue) and Senp2 (dark blue) in complex with SUMO-1 made by superimposing the respective
N-terminal Senp2 subdomains (see text for amino acid numbers). SUMO-1 is represented by a thin gray line. The Senp2 residues involved in
interactions with SUMO-1 are labeled and shown in bond representation.
In contrast, Senp2 and Ulp1 can deconjugate large Arg63 and Asp413 and the aliphatic side chain atoms
from Leu65, Arg63, and Tyr91 that form a complementarySUMO-protein adducts due to the relatively open config-
uration of the active site and the lack of an analogous hydrophobic pocket that accommodates the Phe441 side
chain from Senp2, a residue conserved in all knowncrossover loop as observed in UCH enzymes. As such,
Senp2 could allow large protein conjugates to come Senp/Ulp family members (Figure 4B). The significance
of these interactions was previously confirmed throughwithin a distance suitable for recognition of the isopep-
tide bond by the active site. a complementary mutational analysis in yeast within the
context of the Ulp1-Smt3 complex (Mossessova and
Lima, 2000). In that study, mutation of Asp451 (equiva-The SUMO-1/Senp2 Interface
SUMO-1-Senp2 interface covers an entire face of the lent to Asp413 in Senp2) and Phe474 (Phe441 in Senp2)
produced conditional lethality in yeast.protease, burying 1800 A˚2 of total accessible surface
area as calculated with GRASP (Nicholls et al., 1991). A second major site of interaction between Senp2 and
the SUMO-1 C-terminal Gly-Gly motif (Gly96-Gly97 inDespite sharing only 41% and 29% sequence identity
to the yeast counterparts, the SUMO-1 and Senp2 inter- SUMO-1) occurs near the Senp2 active site. The confor-
mation of the C-terminal tail over the active site suggestsface can be described in the context of the same six
conserved motifs present in the Ulp1-Smt3 structure that substrates must pass through a constricted hy-
drophobic tunnel within the active site during cleavage(Figure 1) (Mossessova and Lima, 2000). Senp2 motifs
1 and 4 form the sides of the interface while the center (Figure 4A). This tunnel is mainly formed by Trp410 (motif
2) and Trp479 (motif 5) in interactions with SUMO-1of the interface is formed by motifs 2, 3, and 5. Motif 6
residues mainly contribute to formation of the Senp2 Gly96 and Gly97, respectively. The orientation of the
peptide suggests that binding would be hindered if ei-active site. One portion of the SUMO-1 surface used in
Senp2 interaction involves C-terminal SUMO-1 residues ther position were substituted with any amino acid larger
than glycine. The Gly97 carbonyl oxygen is stabilizedTyr91 to Gly97 (Figure 4A). This region adopts a strand-
like conformation whereby four hydrogen bonds are ob- by interactions with the backbone nitrogen atoms of
Cys548, Asp547, and the N of Gln542 (motif 6). In aserved between the backbone of SUMO-1 and residues
from motifs 2 and 3 (Asp413, Trp410, His474, and true substrate complex, the C-terminal SUMO-1 Gly-Gly
motif would either be linked to a lysine side chain fromVal477). The extended C-terminal SUMO-1 peptide
chain ends with the covalent thiohemiacetal bond be- a SUMO-conjugate or to C-terminal amino acid residues
within the context of the SUMO maturation reaction.tween Gly97 and the S atom of Cys548. Gln94 repre-
sents the only extensive side chain interaction observed
between the SUMO-1 C-terminal peptide and Senp2. Functional Characterization of Ulp1/Senp2
Substrate SpecificityGln94 is within hydrogen bonding distance from Thr440
and is buried in a pocket created by Senp2 residues As stated previously, three SUMO variants are observed
in metazoans, although SUMO-2 and SUMO-3 are highlyHis474, Trp479, and Phe441.
A major determinant of the SUMO surface recognized related to one another in their mature forms (Figure 1).
To determine if the catalytic domains from either Senp2by Senp2 includes a conserved salt bridge between
Structure of Senp2 and a Senp2-SUMO Complex
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Figure 4. Stereo Representations of the Senp2-SUMO-1 Interface
(A) Stereo representation of the interaction between the SUMO-1 C-terminal tail (gray) and Senp2 (blue). Residues involved in interaction with
SUMO-1 are labeled and shown in bond representation. Amino acids thought to participate in hydrogen bonding interactions between these
two molecules are denoted by red dashed lines.
(B) Stereo representation focusing on the interactions between SUMO-1 (gray) and Senp2 (blue) that do not involve the Senp2 catalytic
residues. Amino acid residues involved in the interaction are labeled and shown in bond representation with hydrogen bonding patterns
depicted as red dashed lines.
or Ulp1 can distinguish SUMO-1 from either SUMO-2 or identical with the exception of residues C-terminal to
the Gly-Gly motif (Figure 1). Furthermore, the inabilitySUMO-3, comparative proteolysis assays were con-
ducted to generate the mature form of these proteins of Ulp1 to cleave SUMO-2 and SUMO-3 is surprising
based on the high level of conservation between Ulp1from their respective precursor sequences (Figure 5).
Senp2 catalyzes efficient maturation of pre-SUMO-2 and Senp2 within the SUMO binding surface. In addition,
most of the critical SUMO residues involved in contactswhen compared to either pre-SUMO-1 or pre-SUMO-3,
although all SUMO isoforms can be recognized and with either protease are conserved between the various
SUMO isoforms. Despite their similarities, some majorcleaved by Senp2 (Figure 5A). Ulp1 catalytic domain was
able to efficiently recognize pre-SUMO-1 as a substrate differences are observed at the respective C-terminal
ends of each SUMO isoform. While human SUMO-1 hasunder similar conditions, but was less able to catalyze
efficient maturation of pre-SUMO-2 or pre-SUMO-3 (Fig- the C-terminal extension (-GG-HSTV), SUMO-2 has the
shortest extension (-GG-VY), and SUMO-3 has the lon-ure 5B). The SUMO maturation assay utilized 10 nM Ulp1
or Senp2 and 10 M SUMO-1, -2, or -3. In the Ulp1 gest extension (-GG-VPESSLAGHSF) (see alignment,
Figure 1). To determine if the SUMO tails were responsi-reactions, 50% of SUMO-1 was hydrolyzed after 15 min
and SUMO-2 and SUMO-3 were not hydrolyzed at ap- ble for the observed substrate preferences, constructs
were assembled to swap each of the respective tailspreciable rates compared to SUMO-1. In Senp2 reac-
tions, 50% of SUMO-1, SUMO-2, and SUMO-3 were onto each of the SUMO isoforms (Figures 5C and 5D).
SUMO-1 was constructed with the C-terminal tailshydrolyzed after 70, 15, and 160 min, respectively.
The large differences in rates of maturation observed from SUMO-1, -2, or -3 and so on for both SUMO-2 and
SUMO-3 (Figures 5C and 5D). Protease activity assaysfor Senp2 between pre-SUMO-2 and pre-SUMO-3 are
surprising since both SUMO-2 and SUMO-3 are nearly were conducted under similar conditions to that de-
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Figure 5. Comparative Proteolysis Assays for SUMO-1, SUMO-2, and SUMO-3 Processing and Deconjugation by Senp2 and Ulp1
(A) Graphical analysis for a time course measuring the maturation reaction for SUMO-1 (closed circle), SUMO-2 (open circle), and SUMO-3
(closed triangle) by human Senp2. The reaction was stopped at different time points by mixing with SDS-PAGE loading buffer. Enzyme and
substrate concentration were 10 nM and 10 M, respectively.
(B) Same reaction as described in (A), but substituting the S. cerevisiae Ulp1 catalytic domain for Senp2.
(C) Upper panel, SDS-PAGE gel analysis for the maturation reaction for SUMO-1 (S1), SUMO-1 with C-terminal tail of SUMO-2 (S1-T2), SUMO-1
with C-terminal tail of SUMO-3 (S1-T3), SUMO-2 (S2), SUMO-2 with C-terminal tail of SUMO-1 (S2-T1), SUMO-2 with C-terminal tail of SUMO-3
(S2-T3), SUMO-3 (3), SUMO-3 with C-terminal tail of SUMO-1(S3-T1), and SUMO-3 with C-terminal tail of SUMO-2 (S3-T2) by human Senp2
(10 nM). The reaction was stopped after 30 min by mixing with SDS-PAGE loading buffer. Lower panel, SDS-PAGE analysis for the maturation
and deconjugation reaction for SUMO-1 (S1), RanGAP1 conjugated to SUMO-1 (RG-S1), Gly-Gly insertion mutant of SUMO-1 after the natural
Structure of Senp2 and a Senp2-SUMO Complex
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scribed for data presented in Figures 5A and 5B, but for To determine if more subtle preferences for SUMO
isoforms still existed, time course assays were con-single time points at 30 min. Senp2 proteolysis assays of
these SUMO hybrids reveals that most of the specificity ducted using 20-fold less protease than was used to
generate Figures 5A–5D. SUMO deconjugation and mat-observed for the native SUMO isoforms can be attrib-
uted to the respective SUMO tail (Figure 5C). As stated uration of SUMO isoforms containing the additional Gly-
Gly insertions are presented in Figures 5E–5H. As above,previously, Senp2 most readily cleaves pre-SUMO-2,
but is less able to cleave either pre-SUMO-1 or pre- Senp2 loses its ability to discriminate between SUMO-1,
-2, and -3 under these conditions, and while Ulp1 gainsSUMO-3 by comparison. By placing the SUMO-2 tail on
either SUMO-1 or SUMO-3, SUMO-1 and SUMO-3 are the ability to interact with all SUMO isoforms in these
assays, Ulp1 still retains a slight preference for SUMO-1.now rendered suitable substrates for Senp2. In contrast,
Senp2 has the most difficulty processing pre-SUMO-3, In an attempt to reveal the basis for Ulp1 specificity,
structure and sequence-based alignments for SUMOand both pre-SUMO-1 and pre-SUMO-2 can be turned
into poor substrates by fusing them to the SUMO-3 tail. and Senp isoforms were again analyzed to identify re-
gions of the Senp-SUMO interface that could accountThe data obtained for Ulp1 is as easily interpreted since
it is only able to process pre-SUMO-1 with either a for the remaining differences observed for Ulp1 activity.
SUMO-1 Leu65, Arg70, and His75 are substituted inSUMO-1 or SUMO-2 tail, but is less able to process
any other combination, suggesting that Ulp1 includes SUMO-2/3 to arginine, proline, and aspartic acid, re-
spectively (Figures 1, 4B, and 6). Leu65 and Arg70 areelements in its SUMO binding site to permit cleavage
of SUMO-1, but not of either SUMO-2 or -3. conserved in Smt3 while His75 is conservatively substi-
tuted to glutamine in Smt3. In the Senp2-SUMO-1 struc-Based on the data presented thus far, we sought to
further evaluate the importance of amino acid side ture, Leu65 appears important for hydrophobic interac-
tions with Phe441, Arg70 interacts directly with Glu414,chains in residues C-terminal to the respective cleavage
sites within each SUMO isoform. To test this, Senp2 and and His75 is proximal to Lys394 (Figure 6C). Senp2
Phe441, Glu414, and Lys394 all reside within the inter-Ulp1 catalytic domains were assayed in deconjugation
reactions using SUMO-1, -2, and -3 conjugated to the face between Senp2-SUMO-1, and substitution at these
positions within respective family members might elicitC-terminal domain of RanGAP1 (Figures 5C and 5D,
lower panels). In this case, the residue C-terminal to the differences in substrate specificity (Figure 6A). Lys394
is conservatively substituted among many of the Senp/cleavage site is an aliphatic -linked lysine side chain.
To partially mimic the -amine linked lysine side chain, Ulp family members, but is substituted to glycine in
Senp6 and Senp7, and Asn432 in Ulp1 (Figures 6A andan additional Gly-Gly di-peptide was inserted C-ter-
minal to the conserved Gly-Gly motif to generate pre- 6C). To test whether Ulp1 Asn432 was important, we
mutated Asn432 to lysine to render Ulp1 more similarSUMO-1, -2, and -3 with the C-terminal extensions (-GG-
GG-HSTV), (-GG-GG-VY), and (-GG-GG-VPESSLAGHSF), to Senp2. Proteolysis assays using this mutant Ulp1
isoform revealed no differences in activity, indicatingrespectively.
Senp2 was able to efficiently hydrolyze SUMO-1, -2, that the subtle preference exhibited by Ulp1 for SUMO-1
could not be explained by analysis of either Ulp1-Smt3and -3 from RanGAP1, and was able to process the pre-
SUMO isoforms containing additional Gly-Gly insertions or Senp2-SUMO-1 structures.
Interesting, 20-fold less Ulp or Senp is required toat nearly equivalent rates, indicating that Senp2 sub-
strate specificity for SUMO-1, -2, or -3 could be attrib- cleave SUMO isoforms from RanGAP, indicating that
both proteases interact more readily with SUMO iso-uted to the amino acid side chains C-terminal to the
cleavage site (Figure 5C, lower panel). Ulp1 also gained forms within the context of a lysine isopeptide linked
conjugate. Consistent with this observation, both prote-the ability to recognize all three SUMO isoforms that
contained the additional Gly-Gly insertion or were conju- ases are more able to interact with and cleave pre-
SUMO isoforms that contain an additional Gly-Gly inser-gated to a lysine within RanGAP1, indicating that the
inability of Ulp1 to catalyze proteolysis of SUMO-2 and tion C-terminal to the cleavage site. Past discussion of
the structural attributes of the active site observed inSUMO-3 in maturation reactions could be attributed to
amino acid side chains C-terminal to the cleavage site both Senp/Ulp-SUMO complexes largely focused on the
hydrophobic tunnel through which the conserved SUMO(Figure 5D, lower panel).
C-terminal Gly-Gly motif (S1-GG), SUMO-2 (S2), RanGAP1 conjugated to SUMO-2 (RG-S2), Gly-Gly insertion mutant of SUMO-2 after the
natural C-terminal Gly-Gly motif (S2-GG), SUMO-3 (S3), RanGAP1 conjugated to SUMO-3 (RG-S3), and Gly-Gly insertion mutant of SUMO-3
after the natural C-terminal Gly-Gly motif (S3-GG) by human Senp2 (10 nM). The reaction was stopped after 30 min by mixing with SDS-PAGE
loading buffer. Positive and negative signs underneath panels indicate the relative efficiency of the reaction. Labels for SDS-PAGE gels mark
approximate locations of the respective substrates and products of the reactions.
(D) Same reaction as described in (C), but substituting the S. cerevisiae Ulp1 catalytic domain for Senp2.
(E) Graphical analysis for a time course measuring the deconjugation reaction for human RanGAP1 conjugated to SUMO-1 (closed circles),
SUMO-2 (open circles), and SUMO-3 (closed triangles) by human Senp2. The reaction was stopped at different time points by mixing with
SDS-PAGE loading buffer. Enzyme and substrate concentration were 0.5 nM and 3 M, respectively.
(F) Same reaction as described in (E), but substituting the S. cerevisiae Ulp1 catalytic domain for Senp2.
(G) Graphical analysis for a time course measuring the maturation reaction for the C-terminal Gly-Gly insertion mutants of SUMO-1 (closed
circles), SUMO-2 (open circles), and SUMO-3 (closed triangles) by human Senp2. The reaction was stopped at different time points by mixing
with SDS-PAGE loading buffer. Enzyme and substrate concentration were 0.5 nM and 10 M, respectively.
(H) Same reaction as described in (G), but substituting the S. cerevisiae Ulp1 catalytic domain for Senp2.
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Figure 6. Surface Representation of the Interaction between Senp2-SUMO-1 and Ulp1-Smt3
(A) Surface representation of SUMO-1 in contact with Senp2: surface oxygen atoms are colored red and nitrogen atoms are blue. Senp2 is
shown as a thin blue line, labeling and depicting the bond representation of the residues in contact with SUMO-1.
(B) Same orientation as (A), showing the surface representation of the Smt3 in contact with Ulp1. Ulp1 is shown as a thin yellow line, labeling
and depicting the bond representation of the residues in contact with Smt3.
(C) Surface representation of human Senp2 interface with SUMO-1. Surface oxygen atoms are colored red and nitrogen atoms are blue.
SUMO-1 is shown as a thin blue line, labeling and depicting the bond representation of the residues in contact with Senp2.
(D) Same orientation as (C), but showing the surface representation of Ulp1 in contact with Smt3. Smt3 is shown as a thin yellow line, labeling
and depicting the bond representation of the residues in contact with Ulp1.
(E) Same as (C), but rotated to look into the back of the active site where residues C-terminal to the cleavage site in SUMO would be located
in a substrate complex.
(F) Same as (E), but viewing the Ulp-Smt3 complex. Protease residues surrounding the active site are labeled on the surfaces of (E) and (F).
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C-terminal tail swap mutants; and the SUMO-1, -2, and -3 Gly-GlyGly-Gly motif must pass. However, substrate prefer-
C-teminal insertion mutants (10 M) were incubated with purifiedences C-terminal to the cleavage site suggests that de-
Ulp1 or Senp2 (10 or 0.5 nM) at 23C in buffer containing 25 mMterminants exist within respective catalytic domains that
Tris-HCL (pH 8.0), 150 mM NaCl, 0.1% Tween-20, and 2 mM DTT.
favor interaction with lysine conjugates or substrates Time points were taken and the reaction was analyzed by sodium
that do not include side chains C-terminal to the cleav- dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE)
age site. Inspection of the active sites in Figures 6E and followed by SYPRO staining (Bio-Rad). Protein quantitation was
performed using a Gel-Doc apparatus with associated integration6F reveal a relatively apolar entrance into the hydropho-
software (Quantity-One; Bio-Rad). Processing of SUMO-modifiedbic tunnel, including contributions from Trp410, Val477,
human RanGAP1 was similarly assayed by incubating conjugatedHis478, Met497, and Gly545 in Senp2 and Trp448,
N419-RanGAP1-SUMO-1, -2, and -3 (3 M) with purified Ulp1 or
Leu510, Ser513, His514, Leu533, and Gly577 in Ulp1. Senp2 (0.5 nM) at 23C and the reaction was analyzed by SDS-
While we are currently unable to attribute specificity PAGE.
for lysine conjugates to any one particular position, the
slightly constricted nature of the tunnel combined with Crystallization and Data Collection
Senp2 crystallization was performed at 4C using sitting and hangingits hydrophobic character are both consistent with the
drop vapor diffusion methods. The reservoir solution contained 20%observed biochemical data. Although the in vivo rele-
polyethylene glycol (PEG) 4000, 0.2 M ammonium sulfate, 3% xylitol,vance of this observation cannot be addressed directly
and 50 mM sodium citrate, pH 6.25. Single plate-shaped crystalsby our biochemical and structural studies, these data
were grown after 3–4 days from equal volumes of protein solution
suggest that the Senp/Ulp clan of proteases have (13 mg/ml in 5 mM Tris, pH 8.0, 25 mM NaCl) and reservoir solution.
evolved to maintain their ability to cleave -peptide link- Prior to diffraction, the crystals were cryo protected in reservoir
ages while developing the ability to specifically recog- buffer containing 12% glycerol and flash-frozen in liquid nitrogen.
Diffraction data were recorded from 100 K cryocooled crystals atnize -linked lysine side chains C-terminal to the cleav-
beamline X4A at the National Synchrotron Light Source (Brookha-age site. However, the apparent lack of substrate
ven, NY). Data were integrated, scaled, and merged using DENZOspecificity toward SUMO conjugates observed for either
and SCALEPACK (Otwinowski and Minor, 1997). Senp2 crystals be-Senp/Ulp catalytic domains further support the idea that
longed to the monoclinic space group C2 with cell dimensions a 
Senp/Ulp SUMO deconjugating activity is regulated 123.24 A˚, b  59.23 A˚, c  94.02 A˚ and   111.29; and contain
through cellular localization in a manner dependent on two molecules per asymmetric unit (VM  3.25 A˚3/Da and 62.21%
the more weakly conserved N-terminal domains ob- [v/v] solvent content).
The Senp2-SUMO-1 complex was crystallized at 18C using sittingserved in most Senp family members.
and hanging drop vapor diffusion methods. The reservoir solution
contained 2 M ammonium sulfate, 5% PEG 400, and 0.1 M bis-trisExperimental Procedures
(pH 6.5). Single hexagonal-shaped crystals were grown after 3–4
days from equal volumes of protein solution (13 mg/ml in 5 mM Tris-cDNA Cloning and Protein Purification
HCl, pH 8.0, 25 mM NaCl) and reservoir solution. Prior to diffraction,A human Senp2 cDNA clone was amplified from a human testes
cDNA library (Clontech) by PCR, and the sequence was found to the crystals were cryo protected in reservoir buffer containing 12%
be identical to the reported sequence for Senp2 (GenBank number glycerol and flash-frozen in liquid nitrogen. Diffraction data were
AF151697). An N-terminal His-tagged human Senp2 (364-489)p was recorded from 100 K cryocooled crystals at SGX-CAT beam line at
expressed from the pET28b in E. coli BL21(DE3) codon plus cells the Advanced Photon Source (Argonne, IL). Data were integrated,
(Novagen), purified by Ni-NTA-agarose resin (Qiagen), and dialyzed scaled, and merged using DENZO and SCALEPACK (Otwinowski
(25 mM Tris-HCl [pH 8.0], 200 mM NaCl, and 2 mM -mercaptoetha- and Minor, 1997). The Senp2-SUMO-1 crystals belonged to the hex-
nol) in the presence of thrombin (Sigma). After thrombin cleavage, agonal space group P6522 with cell dimensions a  b  111.16 A˚,
Senp2 was further purified using a gel filtration Superdex200 column and c  143.11 A˚; and contain one protein complex per asymmetric
(Amersham-Pharmacia). N-terminally His-tagged SUMO-1 (18-101)p unit (VM  3.84 A˚3/Da and 68.01% [v/v] solvent content).
was expressed from pET28b in E. coli BL21(DE3) codon plus cells
(Novagen), purified by Ni-NTA-agarose resin (Qiagen) and by gel Structure Determination and Refinement
filtration (Superdex75; Amersham-Pharmacia). The covalent adduct The Senp2 structure was solved by molecular replacement using
was prepared by mixing Senp2 and SUMO-1 at a 1:3 molar ratio the coordinates of the yeast ortholog Ulp1 as a search model with
with consecutive additions of sodium borohydride (NaBH4) over 30 the program CNS (Bru¨nger et al., 1998). The model was traced
min to a final concentration of 50 mM to yield 20%–30% of the manually into the electron density map using the program O (Jones
desired product. The reaction mixture was dialyzed and further puri- et al., 1991). Refinement was performed with CNS and REFMAC at
fied by cation exchange (MonoS, Pharmacia).
the last stages (CCP4, 1994). The refined model at 2.2 A˚ consists
SUMO-2 and SUMO-3 were isolated by PCR from a human testes
of two molecules of 1872 protein atoms and 225 water molecules.
library (Clontech) and found identical to the reported sequences of
All defined amino acid residues exhibit main chain angles falling
SUMO-2 (GenBank number X99584) and SUMO-3 (GenBank number
into the most favored (91.2%) or additionally favored regions (8.4%)AK024823). Full-length SUMO-1, SUMO-2, and SUMO-3 were ex-
of the Ramachandran plot (Laskowski et al., 1993).pressed from pET28b in E. coli BL21(DE3) codon plus cells (Nova-
The Senp2-SUMO-1 structure was solved by molecular replace-gen) and purified by excluding the native stop codon and fusing a
ment (AMoRe) using the structure of the free Senp2 as a searchC-terminal hexa-histidine tag C-terminal to the native polypeptide.
model (Navaza, 1994). The model was traced manually into theSUMO-1, -2, and -3 were purified by Ni-NTA-affinity chromatography
electron density map using the program O. Refinement was per-(Qiagen) and by anion exchange.
formed with CNS and REFMAC at the final stages. The refined modelHybrids of SUMO-1 with the SUMO-2 and -3 tail, SUMO-2 with
at 2.8 A˚ consists of one protein complex of 1861 (Senp2) and 610the SUMO-1 and -3 tail, and SUMO-3 with the SUMO-1 and -2 tail
(SUMO-1) protein atoms and 81 water molecules. All defined aminowere generated by PCR. Insertion of two additional glycine residues
acid residues exhibit main chain angles falling into the most favoredafter the native Gly-Gly motif of SUMO-1, -2, and -3 were generated
(86%) or additionally favored regions (13.6%) of the Ramachandranby PCR using the QuikChange Site-Directed Mutagenesis Kit (Stra-
plot (Laskowski et al., 1993).tagene). All mutants were produced in E.coli and purified similarly
to the native proteins.
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ited in the PDB under ID codes 1THO and 1TGZ, respectively.
